Victoria Socha

DocwireNews

Kidney Week 2020Hispanics are the largest minority group in the United States. Compared with non-Hispanic Whites, Hispanics are more likely to develop end-stage renal disease (ESRD), yet are less likely to receive a deceased-donor kidney <a href="https://www.docwirenews.com/nephtimes/nephtimes-features/nephtimes-focus-on-transplantation/cognitive-function-among-patients-evaluated-for-kidney-transplantation/">transplant</a>. To examine barriers to transplantation among Hispanic Patients with ESKD, Armando T. Cardenas, MD, and colleagues at the University of the Incarnate Word, San Antonio, Texas, conducted an analysis of data from clinics on the Mexican-American border.Results of the analysis were reported during a virtual poster session at ASN Kidney Week 2020. The <a href="https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3449207">poster</a> was titled Patient Barriers to Kidney Transplantation on the Mexican American Border.Data were collected from three dialysis clinics in Laredo, Texas. Laredo has a population of ~250,000, 95.6% of whom are Hispanic. The researchers determined the number of patients waitlisted or scheduled for living-donor transplantation as well as the number of patients who were referred but not listed and those who were not referred at all. Reasons for nonreferral were also investigated.The analysis included 285 patients. Of those, 18.2% (n=52) were waitlisted or scheduled for living-donor transplantation, 31.9% (n=91) were referred but not yet waitlisted or scheduled for living-donor transplantation, and 49.1% (n=140) were not referred.Among the 140 patients not referred for evaluation for transplantation, the most common reasons were advanced age (25%), weight (4.2%), malignancy (2.85%), cardiovascular complications (4.2%), peripheral vascular disease (3.57%), functional status (5.71%), noncompliance (5.71%), transportation issues (10.71%), and immigration status (7.14%).In conclusion, the researchers said, &ldquo;Nearly half of ESRD patients were not referred for transplant evaluation and less than half of those referred were waitlisted or scheduled for living-donor transplantation. This is lower than previous studies showing a greater percentage of referred patients as waitlisted (up to 66% in some studies). Major barriers to referral included age, immigration status, and transportation limitations. The latter two barriers are likely more a factor in a Mexican-American border town than in other areas of the United States. Identifying these barriers highlight areas for improvement in access to renal transplantation for Hispanics.&rdquo;Source: Cardenas AT, Georffino JPZ, Mcnutt G. Patient barriers to kidney transplantation on the Mexican American border. Abstract of a poster presented at the American Society of Nephrology virtual Kidney Week 2020 (PO2494), October 22, 2020.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Barriers to Kidney Transplantation among Hispanics in Laredo, Texas

Kidney Transplantation

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe